This trial is testing whether the TriClip device is safe and effective in improving outcomes for people with severe tricuspid regurgitation who are at risk for mortality or morbidity with tricuspid valve surgery.
1 Primary · 4 Secondary · Reporting Duration: 12 Months
700 Total Participants · 4 Treatment Groups
Primary Treatment: Tricuspid valve repair · No Placebo Group · N/A
Age 18+ · All Participants · 9 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: